— Know what they know.
Not Investment Advice

SILO NASDAQ

Silo Pharma, Inc.
1W: -16.6% 1M: -41.6% 3M: -76.5% YTD: +335.0% 1Y: +113.0% 3Y: -15.6% 5Y: +689.2%
$1.46
-0.04 (-2.80%)
 
Weekly Expected Move ±8.0%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 27 · $1.6M mcap · 1M float · 14.23% daily turnover · Short 53% of daily vol

Balance Sheet Trends

Total Assets
$217K -97.1% ▼
5Y CAGR: -31.4%
Total Liabilities
$1M -45.3% ▼
5Y CAGR: +54.9%
Shareholders Equity
$6M +25.3% ▲
5Y CAGR: +37.5%
Cash & Investments
$7M -3.1% ▼
5Y CAGR: +43.5%
Total Debt
$0 +0.0% ▲
Net Debt
-$5M -21.6% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$10M$11M$4M$4M$5M
Short-Term Investments$420K$3K$4M$3M$2M
Cash & ST Investments$10M$11M$8M$7M$7M
Net Receivables$0$66K$0$0$0
Inventory$0$0$0$0$0
Other Current Assets$145K$0$16K$31K$529K
Total Current Assets$10M$12M$8M$7M$7M
Property, Plant & Equip.$0$0$0$0$0
Goodwill & Intangibles$0$0$0$241K$217K
Long-Term Investments$61K$0$0$0$0
Other Non-Current Assets$27K$71K$65K$59K-$7M
Total Non-Current Assets$88K$71K$65K$300K-$7M
Total Assets$10M$12M$8M$7M$217K
— Liabilities —
Accounts Payable$418K$364K$703K$2M$578K
Short-Term Debt$0$0$0$0$0
Deferred Revenue$72K$72K$72K$72K$72K
Other Current Liabilities$0$0$0$0$0
Total Current Liabilities$490K$436K$776K$2M$650K
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$938K$866K$794K$722K$649K
Total Liabilities$1M$1M$2M$2M$1M
— Equity —
Common Stock$10K$316$316$449$1K
Retained Earnings-$3M-$7M-$11M-$15M-$19M
Accumulated OCI$0$0-$6K$2K$6K
Total Stockholders Equity$9M$10M$6M$5M$6M
Total Liabilities & Equity$10M$12M$8M$7M$8M
— Key Metrics —
Total Debt$0$0$0$0$0
Net Debt-$10M-$11M-$4M-$4M-$5M
Total Investments$481K$3K$4M$3M$2M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms